Abstract
1302P Treatment outcomes and safety of durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in Thai populations: A real-world, multi-center observational study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have